8 and Wang, et al
The 503A Bulks List is part of the FDAs regulatory framework for compounding pharmacies
Through this intracellular coupling, astrocytes supply neurons with cysteine or cysteinyl-glycine derived from exported GSH, thereby supporting neuronal GSH synthesis and resistance to damaging, redox-driven processes (Kwon et al., 2019)
Summary of the FDA News Release: The FDA just closed the door on compounded GLP-1s and the market implications are enormous
I co-wrote this piece to unpack why habits, mindset, and support systems are the true drivers of sustainable GLP1 success
Treatment with Dulaglutide has been found to reduce binge eating frequency, body weight, body mass index, body fat percentage, and glycated hemoglobin in diabetic patients with binge eating disorder